Hirbe AC - Search Results

1

The protein 4.1 tumor suppressor, DAL-1, impairs cell motility, but regulates proliferation in a cell-type-specific fashion.

Gutmann DH, Hirbe AC, Huang ZY, Haipek CA. Gutmann DH, et al. Among authors: hirbe ac. Neurobiol Dis. 2001 Apr;8(2):266-78. doi: 10.1006/nbdi.2000.0376. Neurobiol Dis. 2001. PMID: 11300722

2

CDK4/6 inhibition enhances SHP2 inhibitor efficacy and is dependent upon restoration of RB function in malignant peripheral nerve sheath tumors.

Wang J, Calizo A, Zhang L, Pino JC, Lyu Y, Pollard K, Zhang X, Larsson AT, Conniff E, Llosa N, Wood DK, Largaespada DA, Moody SE, Gosline SJ, Hirbe AC, Pratilas CA. Wang J, et al. Among authors: hirbe ac. bioRxiv [Preprint]. 2023 Feb 3:2023.02.02.526674. doi: 10.1101/2023.02.02.526674. bioRxiv. 2023. Update in: Sci Adv. 2023 Nov 24;9(47):eadg8876. doi: 10.1126/sciadv.adg8876 PMID: 36778419 Free PMC article. Updated. Preprint.

3

A Retrospective Multi-Institutional Cohort Analysis of Clinical Characteristics and Outcomes in Dedifferentiated Chondrosarcoma.

Bui N, Dietz H, Farag S, Hirbe AC, Wagner MJ, Van Tine BA, Ganjoo K, Jones RL, Keedy VL, Davis EJ. Bui N, et al. Among authors: hirbe ac. Cancers (Basel). 2023 May 5;15(9):2617. doi: 10.3390/cancers15092617. Cancers (Basel). 2023. PMID: 37174084 Free PMC article.

4

Molecular analysis of malignant triton tumors.

Strauss BL, Gutmann DH, Dehner LP, Hirbe A, Zhu X, Marley EF, Liapis H. Strauss BL, et al. Hum Pathol. 1999 Aug;30(8):984-8. doi: 10.1016/s0046-8177(99)90255-1. Hum Pathol. 1999. PMID: 10452514

5

Developmental regulation of a neuron-specific neurofibromatosis 1 isoform.

Gutmann DH, Zhang Y, Hirbe A. Gutmann DH, et al. Ann Neurol. 1999 Nov;46(5):777-82. doi: 10.1002/1531-8249(199911)46:5<777::aid-ana15>3.0.co;2-h. Ann Neurol. 1999. PMID: 10553997

6

Functional analysis of neurofibromatosis 2 (NF2) missense mutations.

Gutmann DH, Hirbe AC, Haipek CA. Gutmann DH, et al. Among authors: hirbe ac. Hum Mol Genet. 2001 Jul 1;10(14):1519-29. doi: 10.1093/hmg/10.14.1519. Hum Mol Genet. 2001. PMID: 11448944

7

BRAFV600E mutation in sporadic and neurofibromatosis type 1-related malignant peripheral nerve sheath tumors.

Hirbe AC, Pekmezci M, Dahiya S, Apicelli AJ, Van Tine BA, Perry A, Gutmann DH. Hirbe AC, et al. Neuro Oncol. 2014 Mar;16(3):466-7. doi: 10.1093/neuonc/not248. Epub 2013 Dec 22. Neuro Oncol. 2014. PMID: 24366910 Free PMC article. No abstract available.

8

Neurofibromatosis type 1: a multidisciplinary approach to care.

Hirbe AC, Gutmann DH. Hirbe AC, et al. Lancet Neurol. 2014 Aug;13(8):834-43. doi: 10.1016/S1474-4422(14)70063-8. Lancet Neurol. 2014. PMID: 25030515 Free article. Review.

9

Morphologic and immunohistochemical features of malignant peripheral nerve sheath tumors and cellular schwannomas.

Pekmezci M, Reuss DE, Hirbe AC, Dahiya S, Gutmann DH, von Deimling A, Horvai AE, Perry A. Pekmezci M, et al. Among authors: hirbe ac. Mod Pathol. 2015 Feb;28(2):187-200. doi: 10.1038/modpathol.2014.109. Epub 2014 Sep 5. Mod Pathol. 2015. PMID: 25189642 Free PMC article.

10

A multidisciplinary approach in neurofibromatosis 1--authors' reply.

Epstein JA, Ingram DA Jr, Hirbe AC, Gutmann DH. Epstein JA, et al. Among authors: hirbe ac. Lancet Neurol. 2015 Jan;14(1):30-1. doi: 10.1016/S1474-4422(14)70298-4. Lancet Neurol. 2015. PMID: 25496893 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

90 results

Search Page

Filters